ProteinLogic Attends JP Morgan 2020
CAMBRIDGE, UK (2020-01-17) – ProteinLogic, the biomarker discovery and exploitation company, has attended the JP Morgan Health week in San Francisco. CEO Nicolas Huber, who represented the company, attended a number of industry events to promote the innovative diagnostic technology of the company. He held meetings with a number of potential commercial partners, who showed significant interest in supporting the company in bringing its leading TB asset to the market. The company is actively following up on all the opportunities attending this event has presented.